Importantly, a concentration gradient- and time-dependent downregulation would also explain our observation of a strong correlation between CXCL13 expression and the presence of its receptor within breast cancer tissues despite the lack of CXCR5 overexpression in the same tissues. This evidence concerns the gene CXCL13 and breast cancer.